Evaluating the Efficacy and Safety of Various LupusNephritis Therapies: Systematic Review and Network Meta-analysis (ERA 2026) - Apr 13, 2026 - Abstract #2316; Pres time: Jun 4, 2026; 10:00 AM - 11:00 AM; Location: Research Zone; "Recent therapeutic trends have shifted from traditional immunosuppressants to emerging agents, such as calcineurin inhibitors (e.g., Tacrolimus, Voclosporin) and biologics (e.g., Belimumab, Rituximab, Obinutuzumab, Anifrolumab). Treatment decisions should carefully balance superior efficacy against these drug-specific safety profiles. Image"
Retrospective data • Review • Glomerulonephritis • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Ting-Yu Chen 1; Jenq-Wen Huang1
|